SR8278

CAS No. 1254944-66-5

SR8278 ( —— )

Catalog No. M21127 CAS No. 1254944-66-5

SR8278 is an REV-ERBα antagonist(EC50 = 0.47 μM) blocking activation of the receptor by the synthetic agonist GSK 4112.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 112 In Stock
10MG 177 In Stock
50MG 414 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SR8278
  • Note
    Research use only not for human use.
  • Brief Description
    SR8278 is an REV-ERBα antagonist(EC50 = 0.47 μM) blocking activation of the receptor by the synthetic agonist GSK 4112.
  • Description
    SR8278 is an REV-ERBα antagonist(EC50 = 0.47 μM) blocking activation of the receptor by the synthetic agonist GSK 4112.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    REV-ERBα
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1254944-66-5
  • Formula Weight
    361.48
  • Molecular Formula
    C18H19NO3S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10mg/ml(27.66mM)
  • SMILES
    CCOC(=O)C1Cc2ccccc2CN1C(=O)c1ccc(SC)s1
  • Chemical Name
    ethyl 2-{[5-(methylsulfanyl)thiophen-2-yl]carbonyl}-1234-tetrahydroisoquinoline-3-carboxylate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kojetin D Wang Y Kamenecka T M et al. Identification of SR8278 a Synthetic Antagonist of the Nuclear Heme Receptor REV-ERB[J]. Acs Chemical Biology 2011 6(2):131-134.
molnova catalog
related products
  • Peroxidase

    Peroxidase comes from horseradish. Peroxidase actively involves in oxidizing reactive oxygen species, innate immunity, hormone biosynthesis and pathogenesis of several diseases.

  • Bisdemethoxycurcumin

    Bisdemethoxycurcumin (BDMC) is a natural demethoxy derivative of curcumin.

  • Ipilimumab

    Ipilimumab anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor.